WAINAMICS, INC.

WAINAMICS, INC. specializes in advanced research and development for physical and engineering sciences, with a focused expertise in designing and implementing sophisticated life science monitoring systems. Their recent SBIR Phase II award for a long-term cell culture monitoring system demonstrates deep technical proficiency in bioreactor instrumentation, real-time physiological data acquisition, and automated environmental control for sustained in vitro cell viability. The company applies precision engineering and sensor integration to solve complex challenges in life science research, with capabilities spanning microfluidics, data logging, and closed-loop system control—tailored for high-fidelity, low-contamination environments critical to space-based and terrestrial biomedical research. WAINAMICS has established a targeted relationship with the National Aeronautics and Space Administration, delivering mission-critical R&D solutions that support life sciences in microgravity and extended-duration spaceflight contexts. Their work for NASA reflects a strong alignment with agency priorities in astrobiology, regenerative medicine, and in-space biological experimentation, suggesting a proven ability to meet the stringent environmental, reliability, and autonomy requirements of spaceflight applications. The contractor’s primary industry focus is in Research and Development in the Physical, Engineering, and Life Sciences, where they position themselves as a niche provider of autonomous, long-duration biological monitoring platforms. Their work bridges engineering innovation with biological experimentation, serving the growing demand for scalable, automated systems in academic, defense, and space research sectors. As a Women-Owned Small Business and Woman-Owned Business certified firm based in Pleasanton, California, WAINAMICS leverages its small business status to engage flexibly with federal innovation programs. The company’s structure supports agile, mission-driven development cycles, and its certifications enhance its eligibility for set-aside SBIR and STTR opportunities, reinforcing its role as a responsive, mission-aligned partner in federal science and technology advancement.